Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer.
dc.contributor.author | Mamdani, Hirva | |
dc.contributor.author | Jalal, Shadia I. | |
dc.contributor.department | Medicine, School of Medicine | en_US |
dc.date.accessioned | 2019-07-05T14:31:53Z | |
dc.date.available | 2019-07-05T14:31:53Z | |
dc.date.issued | 2017-12 | |
dc.identifier.citation | Mamdani, H., & Jalal, S. I. (2017). Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer. Lung cancer management, 6(4), 125–128. doi:10.2217/lmt-2018-0004 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/19847 | |
dc.language.iso | en_US | en_US |
dc.publisher | Future Medicine | en_US |
dc.relation.isversionof | 10.2217/lmt-2018-0004 | en_US |
dc.relation.journal | Lung Cancer Management | en_US |
dc.rights | Publisher Policy | en_US |
dc.source | PMC | en_US |
dc.subject | ALK rearrangement | en_US |
dc.subject | Alectinib | en_US |
dc.subject | Brigatinib | en_US |
dc.subject | Ceritinib | en_US |
dc.subject | Crizotinib | en_US |
dc.subject | Molecularly targeted therapy | en_US |
dc.subject | Non-small-cell lung cancer | en_US |
dc.title | Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer. | en_US |
dc.type | Article | en_US |